Bio-Rad Laboratories | BIO - Selling And Administration Expenses

Stock Price
261.24
Daily Change
-1.56 -0.59%
Monthly
-1.39%
Yearly
1.91%
Q1 Forecast
254.86

Bio-Rad Laboratories reported $206.8M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Agilent USD 476M 48M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bio Techne USD 113.69M 2.52M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
Bruker USD 247.2M 4.7M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Danaher USD 2.03B 35M Dec/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
General Electric Aerospace USD 1.58B 385M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Illumina USD 283M 27M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
Laboratory Of America USD 538.6M 13.8M Dec/2025
Merck USD 2.85B 215M Dec/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Myriad Genetics USD 129M 1.3M Sep/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quest Diagnostics USD 504M 3M Dec/2025
Repligen USD 74.36M 703K Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Siemens EUR 3.61B 489M Dec/2025
Standard Biotools USD 26.6M 1.5M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Tosoh JPY 41.52B 2.62B Dec/2025
Waters USD 240.01M 25.78M Dec/2025